A61P 15 - Drugs for genital or sexual disorders; Contraceptives

Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
11/1997
11/20/1997	WO1997043237A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
11/20/1997	WO1997042959A1 Emergency contraceptive kit
11/20/1997	WO1997042956A1 Didhydropyrimidines and uses thereof
11/20/1997	WO1997035538A3 Tumor necrosis factor alpha convertase
11/20/1997	CA2253876A1 Indole derivatives useful as endothelin receptor antagonists
11/20/1997	CA2253862A1 Dihydropyrimidines and uses thereof
11/20/1997	CA2253289A1 Emergency contraceptive kit
11/19/1997	EP0807684A1 Human G-protein coupled receptor (HIBCD07)
11/19/1997	EP0807633A2 Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
11/19/1997	EP0807628A1 Aromatic compound and pharmaceutical composition
11/19/1997	EP0806952A1 Progesterone antagonists useful for preparing medicaments for treating dysfunctional uterine bleeding
11/19/1997	EP0806947A1 Formulations and methods for reducing skin irritation
11/19/1997	CN1165000A Method of reducing tissue damage associated with ischemia
11/18/1997	US5688818 Enzyme inhibitors
11/18/1997	US5688795 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
11/18/1997	US5688506 Immunogens against gonadotropin releasing hormone
11/18/1997	US5688502 Digestive enzyme immobilized in gel matrix
11/18/1997	US5688499 Antagonism of endothelin actions
11/13/1997	WO1997042322A1 Glycoprotein hormone superagonists
11/13/1997	WO1997042174A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
11/13/1997	WO1997041886A1 Stimulation of host defence mechanisms against tumors
11/13/1997	WO1997041883A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	WO1997041874A1 Phosphatidic acid-comprising compositions
11/13/1997	WO1997041866A1 Improvement of implantation rates after in vitro fertilization
11/13/1997	WO1997041851A1 Benzothiophenes, formulations containing same, and methods
11/13/1997	WO1997041824A2 Antiangiogenic peptides derived from plasminogen
11/13/1997	CA2253908A1 Stimulation of host defence mechanisms against tumors
11/13/1997	CA2253902A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	CA2253858A1 Benzothiophenes, formulations containing same, and methods
11/13/1997	CA2253751A1 Improvement of implantation rates after in vitro fertilization
11/13/1997	CA2253441A1 Glycoprotein hormone superagonists
11/12/1997	EP0806420A1 Benzothiophenes, formulations containing same, and methods
11/12/1997	EP0805813A1 Tricyclic vasopressin antagonists
11/12/1997	EP0805812A1 Bicyclic substituted hexahydrobenz(e)isoindole alpha-1- adrenergic antagonists
11/12/1997	CN1164537A New pseudopeptides derived from neurokinins, process for preparing them and pharmaceutical compositions contianing them
11/12/1997	CN1164418A Magnetic disinfectant antipruritic spray for preventing and curing venereal disease and its preparing method
11/12/1997	CN1036396C Process for preparing (E)-3-£2-n-butyl-1-{(4-carboxyl-phenyl)methyl}-1H-imidazol-5-yl}-2-(2-thienyl) methyl-2-acrylic methylsulfonate
11/12/1997	CN1036392C Method for preparation of ring-substituted 2-amino-tetralin and 3-aminochromanes
11/11/1997	US5686485 Physiologically active EI-1941 compounds
11/11/1997	US5686478 Endothelin antagonists
11/11/1997	US5686467 2-phenyl-3-aroylbenzothiophenes
11/11/1997	US5686460 Antiinflammatory agents, analgesics
11/11/1997	US5686454 Preventing labor, vasodilation, diuresis, hypotensive agents, anticoagulants, treating dysmenorrhea
11/11/1997	US5686444 Selected soluble esters of hydroxyl-containing indolocarbazoles
11/11/1997	US5686425 Composition and method for revitalizing scar tissue
11/11/1997	US5686409 Administering serine protease inhibitor
11/11/1997	US5686289 Seeding hollow fibers with renal tubule cells, culturing in presence of retinoic acid and epidermal growth factor, cell differentiation
11/11/1997	US5686097 Hormone replacement therapy, glycerol monolaurate, lauryl lactate
11/06/1997	WO1997041125A1 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
11/06/1997	WO1997040850A1 Erythropoietin solution preparation
11/06/1997	WO1997033608A3 Antagonism of endothelin actions
11/05/1997	EP0804471A1 Gnrh antagonists
11/05/1997	EP0804440A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997	EP0804435A1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
11/05/1997	EP0804420A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997	EP0804239A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
11/05/1997	EP0804219A1 Inhibin compositions and methods of use thereof
11/05/1997	EP0804209A1 Chemical castration
11/05/1997	EP0804196A1 Use of serotonin antagonists (5ht 3?) for treating fibromyalgia
11/05/1997	EP0804176A1 Transdermal presentation of nitroglycerin for preventing undesired labour
11/04/1997	US5684198 Method of preparing therapeutic amides
11/04/1997	US5684145 Carrier system against GNRH
11/04/1997	US5684047 4-guanidinobutyramide for improving blood circulation
11/04/1997	US5684028 Sulphorous derivatives of imidazole, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions
11/04/1997	US5684015 Angiotensin antagonist as hypotensive agents and cardiovascular disorders
10/1997
10/30/1997	WO1997040158A1 Epimorphin antagonist and process for producing the same
10/30/1997	WO1997040071A1 Compounds with growth hormone releasing properties
10/30/1997	WO1997040070A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip)
10/30/1997	WO1997040023A1 Compounds with growth hormone releasing properties
10/30/1997	WO1997040012A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
10/30/1997	WO1997039768A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
10/30/1997	WO1997039760A1 Combination therapy for treatment of erectile dysfunction
10/30/1997	CA2252761A1 Compounds with growth hormone releasing properties
10/30/1997	CA2252458A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip)
10/30/1997	CA2250869A1 Combination therapy for treatment of erectile dysfunction
10/29/1997	EP0803501A1 Substituted guanidine derivatives and their use as Na+/H+ exchange inhibitors
10/29/1997	EP0803256A1 Drug for relieving side effects caused by immunosuppressants
10/29/1997	EP0493380B1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
10/29/1997	CN1163123A Mongolian medicine for curing venereal disease
10/29/1997	CN1163117A Double-effect preparation for curing prospermia and killing venereal bacteria
10/28/1997	US5681817 Treatment of ovarian estrogen dependent conditions
10/23/1997	WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
10/23/1997	WO1997038983A1 Irreversible inhibitors of tyrosine kinases
10/22/1997	EP0802184A1 N-Benzyl-2-phenylindoles as estrogenic agents
10/22/1997	EP0802183A1 Estrogenic agents
10/22/1997	EP0801656A1 Induction of cytotoxic t-lymphocyte responses
10/22/1997	EP0801554A1 Formulations and methods for reducing skin irritation
10/22/1997	EP0640080B1 Substituted indoles as angiotensin ii antagonists
10/21/1997	US5679683 Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
10/16/1997	WO1997038011A1 Non-dendritic backbone peptide carrier
10/16/1997	WO1997037983A1 α1-ADRENERGIC RECEPTOR ANTAGONISTS
10/16/1997	WO1997037688A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
10/16/1997	WO1997037681A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997	WO1997037666A1 Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents
10/16/1997	WO1997037658A1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents
10/16/1997	WO1997028826A3 Contraceptive release systems with antibacterial and/or antiviral effect
10/16/1997	CA2650637A1 Pharmaceutical composition containing angiotensin ii antagonist
10/16/1997	CA2251464A1 Non-dendritic backbone peptide carrier
10/16/1997	CA2251009A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997	CA2250898A1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents

1 ... 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 ... 557